Xiao-nan Hong
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results.
Journal: The oncologist
Published: January 04, 2024
IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma.
Journal: Cancer medicine
Published: December 14, 2022
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study.
Journal: Chinese medical journal
Published: May 10, 2021
Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma by Using a qPCR-based Gene Expression Assay on Formalin-Fixed Paraffin-Embedded Tissues.
Journal: Frontiers in oncology
Published: February 22, 2020
Prognostic Significance of LDH Ratio in Serum/Cerebral Spinal Fluid of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma.
Journal: OncoTargets and therapy
Published: August 26, 2019
The size and depth of lesions measured by endoscopic ultrasonography are novel prognostic factors of primary gastric diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: October 03, 2018
Advanced breast angiosarcoma completely responding to gemcitabine-containing chemotherapy.
Journal: Breast care (Basel, Switzerland)
Published: October 01, 2012
Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
Journal: PloS one
Published: January 16, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026